TransCode Therapeutics logo
TransCode Therapeutics
RNAZ | NASDAQ
Chart Builder DCF Calculator
$1.35
+$0.03 (+2.27%)
At close: Nov 16, 2026, 4:00 PM ET
$1.37
+$0.02 (+1.48%)
After-hours: Nov 16, 2026, 7:30 PM ET

TransCode Therapeutics Cash Flow Statement

Cash flow statement explained
TTM
Period Ending
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-1.4B -1.4B -1.39B -27.13M -24.6M -25.51M -16.75M -14.93M -17.91M -17.06M -18.55M -19.59M -18.58M -18.91M -17.56M -15.23M -13.27M -5.83M -6.84M -4.85M -3.89M -6.79M
97.43K 86.94K 114.18K 192.25K 314.99K 444.38K 534.86K 552.18K 563.44K 558.19K 516.75K 406.08K 292.1K 177.2K 98.61K 98.09K 80.82K 62.82K 42.47K 13.48K 5.95K 92.86K
-95.71M -95.71M -95.55M 326.5K 530.98K 530.98K 373.25K 204.48K 392.33K 567.82K 726.58K 857.13K 570.4K 493.52K 395.33K 303.77K 198.17K 99.57K 87.43K 61.1K 92.48K 93.18K
1.37M 75.32K 552.71K 345.22K 603.6K 686.04K 568.32K -300.81K -229.2K 494.79K -146.27K 9.63K -1.14M -1.22M -209.7K 145.97K -321.39K -1.33M -1.89M -2.43M -82.41K -342.35K
1.01B 1.01B 1.24B 11.48M 11.06M 11.91M 2.86M 1.64M 483.64K 1.4M 1.22M 904.89K 2.06M 265.92K 265.92K 304.69K -404.87K -3.81M -3.79M -3.44M -1.63M 1.42M
457.38M 457.38M 226.07M – – – – – 1.15M -904.89K -904.89K -904.89K -2.06M -265.92K -265.92K -265.92K -265.92K – 3.98M 3.98M 3.98M 3.98M
4.09M 2.59M 15.69K 617.46K -1.66M 128.74K -351.48K -3.32M -133.97K -2.06M -1.08M 1.9M 372.75K 1.91M 1.31M 1.45M 897.29K -74.72K 396.7K -550.41K 372.19K 201.27K
-22.61M -21.4M -19.52M -14.52M -14.35M -12.5M -13.34M -15.85M -15.45M -17.5M -18.07M -16.43M -17.35M -16.33M -15.76M -13.34M -12.76M -9.55M -6.13M -4.78M -1.07M -996.99K
-6.66K -6.66K -6.66K -498 -13.37K -17.93K -21.76K -21.26K -13K -26.55K -35.61K -63.82K -59.22K -83.16K -100.92K -158.43K -229.98K -210.17K -254.82K -169.09K -97.54K -75.3K
2.22K 2.22K 2.22K – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – 3K 3K 3K 3K – – –
-4.44K -4.44K -4.44K -500 -13.37K -17.93K -21.76K -21.26K -13K -26.55K -35.61K -63.82K -59.22K -83.16K -100.92K -155.43K -226.98K -207.18K -251.82K -169.09K -97.54K -75.3K
950K – – – – – – – – – – – – – – – – – – – – 190K
– – – – – – – – – – – – – – – – – – – – – –
-1.84M -1.73M – – – – – – – – – – – – – – – – – – – –
24.51M 24.39M 22.67M -455.73K – – – – 135.8K – – 225.82K -135.8K 5.98K 5.98K -210.35K -13.8K 141.09K 9.49K -12.43K -44.22K -205.08K
23.62M 22.67M 31.52M 15.48M 18.38M 19.17M 16.4M 10.3M 15.24M 20.82M 15.91M 15.16M 7.54M 1.19M 11.97K -204.36K 26.36M 26.52M 26.38M 26.36M -40.58K -15.08K
1.01M 1.27M 12M 959.96K 4.02M 6.66M 3.04M -5.58M -217.92K 3.29M -2.2M -1.34M -9.87M -15.23M -15.86M -13.71M 13.36M 16.75M 20M 21.4M -1.21M -1.09M
-22.61M -21.4M -19.52M -14.52M -14.36M -12.51M -13.36M -15.87M -15.46M -17.52M -18.11M -16.49M -17.41M -16.41M -15.86M -13.5M -12.99M -9.76M -6.38M -4.95M -1.17M -1.07M
73.09M 74.3M 76.03M -14.85M -14.89M -13.04M -13.73M -16.08M -15.85M -18.09M -18.84M -17.35M -17.98M -16.9M -16.26M -13.81M -13.19M -9.86M -6.47M -5.01M -1.26M -1.17M
-6.67K -6.67K -6.66K -504 -13.37K -17.93K -21.76K -21.26K -13K -26.55K -35.61K -63.82K -59.22K -63.81K -72.51K -73.29K -80.82K -62.82K -42.47K -13.48K -5.95K -1.26K
6 6 6 6 – – – – – – – – – -19.35K -28.4K -85.14K -149.16K -147.35K -212.35K -155.61K -91.59K -74.05K
-22.61M -21.4M -19.52M -14.52M -14.36M -12.51M -13.36M -15.87M -15.46M -17.52M -18.11M -16.49M -17.41M -16.39M -15.84M -13.42M -12.85M -9.62M -6.17M -4.8M -1.08M -998.25K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.